drugset / Trial / NCT02991950

Weight Adjusted Low Molecular Weight Heparin in Recurrent Implantation Failure: a Randomized Open Labeled Trial

NCT02991950 ↗

Phase 3 Terminated 271 enrolled Istituto Clinico Humanitas
RandomizedParallel-groupOpen-labelTreatment

Summary

Prospective randomized study of patients with infertility candidates to Assisted ReproductiveTechniques (ART), screened for all inclusion and exclusion criteria, submitted to ART cycle with or without low molecular weight heparin (LMWH) administration. Aims of the study are to evaluate, primarily, pregnancy rate/embryo transfer, secondarily take home babies/embryo transfer, implantation rate, and the role of thrombophilic factors

Timeline

Start
2011-07
Primary completion
2015-03
Completion
2015-12

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulty with patient enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Subject parnaparin Other / unclassified 100 iu/kg —
Subject parnaparin Other / unclassified 4250 iu —
Subject parnaparin Other / unclassified 6400 iu —

Indications